Evidence of pseudoprogression in patients treated with PD1/ PDL1 antibodies across tumor types
Palabras clave :
Immune checkpoint inhibitor
Pseudoprogression
Response evaluation criteria in solid tumors
Treatment beyond progression
Fecha de publicación :
2020
Nota:
CC-BY. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original
work is properly cited.
Cita:
Martin-Romano, P. (Patricia); Castañon, E. (Eduardo); Ammari, S. (Samy); et al. "Evidence of pseudoprogression in patients treated with PD1/ PDL1 antibodies across tumor types". Cancer Medicine. 9 (8), 2020, 2643 - 2652
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.